1-5 of 5
Tzila Zuckerman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Autologous Versus Related Versus Unrelated Hematopoietic Stem Cell Transplantation for Adult Patients with NPM1 Mutated/FLT3-ITD Negative Acute Myeloid Leukemia in First Remission: A Study from the Acute Leukemia Working Party (ALWP) of the European Society of Blood and Marrow Transplantation (EBMT)

Xavier Poiré, MD, Myriam Labopin, Didier Blaise, MD PhD, Patrice Chevallier, MD PhD, Johan Maertens, MD PhD, Eric Deconinck, MD PhD, Edouard Forcade, MD, Alessandro Rambaldi, MD, Gabriela M. Baerlocher, MD, Tzila Zuckerman, MD, Liisa Volin, MD PhD, Harry C. Schouten, Norbert Ifrah, MD, Jordi Esteve, MD PhD, Mohamad Mohty, Arnon Nagler, MD MSc
Journal: Blood
Blood (2016) 128 (22): 2279.
https://doi.org/10.1182/blood.V128.22.2279.2279
Published: 2016
Journal Articles

Beac and BEAM High-Dose Chemotherapy in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation Are Efficacious, with Comparable Toxicity

Noa Lavi, MD, Ron Ram, MD, Odelia Amit, MD, Netanel A Horowitz, MD, Tzila Zuckerman, MD
Journal: Blood
Blood (2016) 128 (22): 5828.
https://doi.org/10.1182/blood.V128.22.5828.5828
Published: 2016
Journal Articles

Inverse PAR1 Activity of Hematopoietic Stem Cells and BM Stromal Cells Mediates G-CSF-Induced Mobilization By Regulation of Nitric Oxide Generation

Neta Nevo, MD, Shiri Gur-Cohen, PhD, Orit Kollet, PhD, Francesca Avemaria, PhD, Seymen Avci, MSc, Tomer Itkin, PhD, Sagarika Chakrabarty, PhD, Tzila Zuckerman, MD, Benjamin Brenner, MD, Yona Nadir, MD, Irina Zaidman, MD, Myriam Ben Arush, MD, Charles Esmon, PhD, Wolfram Ruf, MD, Tsvee Lapidot, PhD
Journal: Blood
Blood (2016) 128 (22): 3370.
https://doi.org/10.1182/blood.V128.22.3370.3370
Published: 2016
Journal Articles

Allogeneic Hematopoietic Cell Transplantation (HCT) for Advanced Mycosis Fungoides and Sezary Syndrome (MF/SS): Impact of Increasing the Use of Unrelated Donors (UD) - the EBMT Lymphoma Working Party Experience

Rafael F. Duarte, MD PhD, Ariane Boumendil, PhD, Francesco Onida, MD, Herve Finel, Ian H Gabriel, Dr, William Arcese, MD, Paul Browne, MD, Dietrich W. Beelen, Prof. Dr. MD, Guido Kobbe, MD, Joan H Veelken, Reyes Arranz, MD, Hildegard T. Greinix, MD, Stig Lenhoff, MD PhD, Xavier Poiré, MD, Josep Ribera, MD PhD, Jacqueline Thompson, Tzila Zuckerman, Ghulam J. Mufti, MD PhD, Agostino Cortelezzi, MD, Eduardo Olavarria, MD PhD, Anna Sureda, MD PhD, Peter Dreger, MD
Journal: Blood
Blood (2015) 126 (23): 4403.
https://doi.org/10.1182/blood.V126.23.4403.4403
Published: 2015
Journal Articles

Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcome

Clinical Trials & Observations
Eldad J. Dann, Rachel Bar-Shalom, Ada Tamir, Nissim Haim, Menachem Ben-Shachar, Irit Avivi, Tzila Zuckerman, Mark Kirschbaum, Odelia Goor, Diana Libster, Jacob M. Rowe, Ron Epelbaum
Journal: Blood
Blood (2006) 109 (3): 905–909.
https://doi.org/10.1182/blood-2006-04-019901
Published: 2006